Barinthus Biotherapeutics plc
BRNS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$14,571 | -$21,126 | -$19,658 | -$20,591 |
| Dep. & Amort. | $901 | $2,001 | $2,034 | $1,428 |
| Deferred Tax | -$71 | -$25 | -$22 | $3 |
| Stock-Based Comp. | -$415 | -$281 | $468 | $755 |
| Change in WC | -$1,462 | -$2,198 | -$137 | $15,152 |
| Other Non-Cash | $4,892 | $3,520 | $2,413 | $16,339 |
| Operating Cash Flow | -$10,726 | -$18,109 | -$14,902 | $13,086 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $451 | -$32 | -$5 | -$278 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $451 | -$32 | -$5 | -$278 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $837 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $2 | $0 |
| Financing Cash Flow | $0 | $0 | $2 | $837 |
| Forex Effect | -$1,835 | $5,346 | $3,084 | -$7,347 |
| Net Chg. in Cash | -$12,110 | -$12,795 | -$11,821 | $6,298 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $87,784 | $100,579 | $112,400 | $106,102 |
| End Cash | $75,674 | $87,784 | $100,579 | $112,400 |
| Free Cash Flow | -$10,726 | -$18,141 | -$14,907 | $12,808 |